D. Olde Weghuis
The Catholic University of America
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by D. Olde Weghuis.
Cancer Genetics and Cytogenetics | 1996
M.C. Mostert; M.H.J. van de Pol; D. Olde Weghuis; R.F. Suijkerbuijk; A. Geurts van Kessel; J. van Echten; J.W. Oosterhuis; L.H.J. Looijenga
Comparative genomic hybridization (CGH) was carried out on 15 primary testicular germ cell tumors (TGCT) of adolescents and adults and two metastatic residual tumors after chemotherapeutic treatment. The results were compared with karyotypic data obtained form the same tumor specimens after direct harvesting of metaphases or short-term in vitro culture. Both techniques revealed that the most consistent abnormality in primary TGCT is gain of 12p-sequences. Although in most cases over-representation of the complete short arm was observed, CGH revealed a specific amplification of 12p11.1-p12.1 region in two independent primary tumors. In addition, loss of (parts of) chromosome 13 (always involving q31-qter), and gain of (parts of) chromosome 7 (mostly involving q11), (parts of) chromosome 8, and the X chromosome were detected in more than 25% of the tumors by this latter technique. Loss of 6q15-q21 in both residual tumors analyzed may suggest a role for this anomaly in acquired resistance to chemotherapeutic treatment. Overall, the CGH analyses confirmed gains and losses of certain chromosomal regions in TGCT as observed by karyotyping, and thus support their role in the development of these neoplasms. The amplification of a restricted region of 12p in primary TGCT confirms and extends our previous observations and, as such, represents an important step forward in the identification of gene(s) on 12p relevant for the pathogenesis of these tumors.
Cancer Genetics and Cytogenetics | 1994
B. de Leeuw; R.F. Suijkerbuijk; D. Olde Weghuis; A.M. Meloni; Göran Stenman; L.G. Kindblom; M. Balemans; E. van den Berg; Willemina M. Molenaar; Avery A. Sandberg; A. Geurts van Kessel
Fluorescence in situ hybridization (FISH) and molecular analyses of synovial sarcomas with cytogenetically similar (X;18)(p11.2;q11.2) translocations have revealed two alternative breakpoint regions in Xp11.2, one residing in the ornithine aminotransferase-like 1 (OATL1) region and the other one in the related but distinct OATL2 region. As these results were obtained by different groups, we set out to evaluate an extended series of tumors with special emphasis on the two possible X-related breakpoint regions. Together, seven synovial sarcomas were identified with a break in the OATL1 region and six with a break near OATL2, thereby confirming the actual existence of the two alternative Xp breakpoint regions. We speculate that there seems to be a relationship between the occurrence of these breakpoint regions and the histologic phenotype of the tumors, with a predominance of OATL1-related breakpoints in the classical biphasic tumors and of OATL2-related breakpoints in the monophasic fibrous tumors.
Apmis | 1998
R.J. Sinke; M.G.J. van Asseldonk; D.R.H. de Bruijn; J.A. Strijk; G.F.M. Merkx; D. Olde Weghuis; B. de Jong; J.W. Oosterhuis; A. Geurts van Kessel
In a previous study we have defined a subgroup of human malignant extragonadal germ cell tumours that is characterized by complex translocations involving chromosomes 6 and 11 (Echten et al. 1995). Here we report (i) the use of fluorescent in situ hybridization, pulsed field gel electrophoresis and direct visual hybridization techniques to localize the tumour‐associated breakpoint within band 11q13, and (ii) the construction of a phage library enriched for this region to facilitate genomic walks towards the breakpoint. Extensive breakpoint‐flanking contigs were generated and within these contigs six candidate genes could be identified.
Human Molecular Genetics | 1995
B. de Leeuw; M. Balemans; D. Olde Weghuis; A. Geurts van Kessel
Human Molecular Genetics | 1994
D.E. Iles; F. Lehmann-Horn; S.W. Scherer; L.-C. Tsui; D. Olde Weghuis; R.F. Suijkerbuijk; L. Heytens; G. Mikala; A. Schwartz; F.R. Ellis; A.D. Stewart; T. Deufel; Bé Wieringa
Oncogene | 1996
D.R.H. de Bruijn; Ellen Kater-Baats; U. Zechner; H. de Leeuw; M. Balemans; D. Olde Weghuis; U. Hirning-Folz; A. Geurts van Kessel
Human Molecular Genetics | 1994
B. de Leeuw; M. Balemans; D. Olde Weghuis; Raquel Seruca; M. Janz; M.T. Geraghty; S. Gilgenkrantz; H.H. Ropers; A. Geurts van Kessel
Cancer Genetics and Cytogenetics | 1996
M.C. Mostert; M.H.J. van de Pol; J. van Echten; D. Olde Weghuis; A. Geurts van Kessel; J.W. Oosterhuis; L.H.J. Looijenga
Cancer Genetics and Cytogenetics | 1997
A. Geurts van Kessel; N.R. dos Santos; A. Simons; D.R.H. de Bruijn; Anne Forus; Øystein Fodstad; Ola Myklebost; Monique C.M. Balemans; E. Baats; D. Olde Weghuis; R.F. Suijkerbuijk; E. van den Berg; Willemina M. Molenaar; B. de Leeuw
Genomics | 1995
A. van de Wijngaard; D. Olde Weghuis; C.J.C. Boersma; E.J.J. van Zoelen; A. Geurts van Kessel; Wiebe Olijve